Vestis Corporation VSTS 深 沪
等待开盘 02-04 09:30:00 美东时间
6.78
+0.100
+1.50%
华盛通- 最 高6.835
- 今 开6.65
- 成交量 173.28万股
- 最 低 6.515
- 昨 收 6.68
- 总市值 8.95亿
- 52周最高 13.725
- 市盈率 静 --
- 换手率 1.31%
- 52周最低 3.98
- 委 比 51.50%
- 总股本 1.32亿
- 历史最高 22.195
- 量 比 0.76
- 振 幅 4.79%
- 历史最低 3.98
- 每 手 1
- 风险率 2.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
The Analyst Verdict: Vestis In The Eyes Of 4 Experts
Providing a diverse range of perspectives from bullish to bearish, 4 analysts h...
01-09 02:00
Goldman Sachs Downgrades Vestis to Sell, Lowers Price Target to $5.3
Goldman Sachs analyst George Tong downgrades Vestis (NYSE:VSTS) from Neutral to Sell and lowers the price target from $6.3 to $5.3.
01-09 01:43
Vestis CFO Kelly Janzen Departing, Adam K. Bowen Named Interim CFO; Reiterates 2026 Guidance
Vestis Corporation (NYSE: VSTS), a leading provider of uniforms and workplace supplies, today announced that Kelly Janzen, Executive Vice President and Chief Financial Officer, will depart the company to pursue other
2025-12-16 21:10
美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
2025-12-04 09:38
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
Baird Maintains Neutral on Vestis, Raises Price Target to $6.5
Baird analyst Andrew Wittmann maintains Vestis (NYSE:VSTS) with a Neutral and raises the price target from $5 to $6.5.
2025-12-03 02:17
Vestis Stock Slips After Mixed Q4 Earnings Report: Details
Here's a look at the Q4 earnings report from Vestis.
2025-12-02 05:42
Vestis Sees FY2026 Sales $2.680B-$2.735B vs $2.713B Est
Vestis (NYSE:VSTS) sees FY2026 sales of $2.680 billion-$2.735 billion vs $2.713 billion analyst estimate.
2025-12-02 05:20
Vestis Q4 Adj. EPS $0.03 Misses $0.06 Estimate, Sales $712.011M Beat $678.304M Estimate
Vestis (NYSE:VSTS) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.06 by 47.37 percent. This is a 72.73 percent decrease over earnings of $0.11 per share from the same
2025-12-02 05:10
